172@29@17@247!~!172@29@0@53!~!|news|business|moneycontrol-research|rossari-biotech-sharp-recovery-in-legacy-business-adds-to-investment-case-6019061.html!~!news|moneycontrol|com!~!|controller|infinite_scroll_article.php!~!is_mobile=false
App
Moneycontrol AppAndroid AppiOS AppiPad AppAndroid TabBlackberryWindows AppWindows Tab
Subscription
Specials
Stocks
Feedback
Log In
Sign Up
Moneycontrol
Watch experts decode 'The rise of ESG investing' on October 29 at 4pm. Register Now!
you are here: HomeNewsBusinessMoneycontrol Research
  
  1
Last Updated Last Updated : Oct 27, 2020 09:55 AM IST | Source: Moneycontrol.com

Rossari Biotech: Sharp recovery in legacy business adds to investment case

Rossari Biotech's growth is likely to be led by performance chemicals business in the medium term

Anubhav Sahu

To view the full content of this article, you have to be a Pro:

  • Not a Moneycontrol Pro subscriber yet?

Subscribe to Moneycontrol Pro:

What's included:

  • Ad free experience across Platforms
  • 230+ exclusive stories per month
  • Sharpest Opinions & Actionable Insights
  • Exclusive Research & Expert Technical Analysis
  • Daily Newsletter
  • 20+ Technical Picks every week
  • Recovery Tracker
  • Exclusive webinars on varied topics
  • Weekly wrap up and much more!!!
Subscribe to PRO and get unlimited access to premium content at Rs.33/- per month. Use code SUPERPRO